Joel Isaacson & Co Portfolio holdings
Top Buys
Top Sells
Sector Composition
| 1 | Healthcare | 6.58% |
| 2 | Technology | 4.63% |
| 3 | Financials | 4.42% |
| 4 | Communication Services | 4.12% |
| 5 | Consumer Staples | 3.77% |
Similar funds
Joel Isaacson & Co's Q1 2014 Portfolio in Review
As of Q1 2014, Joel Isaacson & Co held 613 positions worth $298M, up 8.2% from $275M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Joel Isaacson & Co deployed $19M of net new capital in Q1 2014, opening 99 new positions and adding to 85 existing holdings. Its largest new stake was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 6.7% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P International Dividend ETF, an estimated $524K trimmed.
- Joel Isaacson & Co's largest Q1 2014 buy was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.
- Joel Isaacson & Co added most to State Street SPDR S&P Dividend ETF in Q1 2014, an estimated $5.6M increase.
- Joel Isaacson & Co's biggest Q1 2014 reduction was State Street SPDR S&P International Dividend ETF, cutting an estimated $524K.
- Joel Isaacson & Co fully exited Vitamin Shoppe Inc. in Q1 2014, selling an estimated $676K.
- Joel Isaacson & Co's ten largest holdings make up 62% of its $298M portfolio in Q1 2014.
- Joel Isaacson & Co opened 99 new positions and closed 20 in Q1 2014.
- Joel Isaacson & Co's portfolio value rose 8.2% quarter-over-quarter to $298M.
Based on Joel Isaacson & Co's 13F filing for Q1 2014, filed 11 Apr 2014.